Carcinoma
📧 Sign up to get email alerts when something new happens for Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) [Phase 2]
Phase 2 clinical trial evaluating ADC with hypofractionated radiotherapy followed by sequential PD-1/PD-L1 blockade with GM-CSF and IL-2 for…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating enzastaurin for persistent or recurrent ovarian or primary peritoneal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma [Phase 1, Phase 2]
Clinical trial of aflibercept with pemetrexed and cisplatin in advanced carcinoma and non-small cell lung cancer was terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis [Phase 3]
Phase 3 trial evaluating lanreotide microparticles for palliative treatment in peritoneal carcinomatosis; completed study assessing efficacy…
-
CLINICAL_TRIALS withdrawal · 2020-05-07Clinical Trial Update: Efficacy and Safety of UGN-101 in Recurrent Patients [Phase 3]
Phase 3 trial of UGN-101 for recurrent carcinoma variants has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in participants with progressive locally advanced/metastatic carcinoma, melanoma, or non-small cell…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating temozolomide for preventing brain metastases in small cell lung cancer is reported as ongoing with un…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer
A non-interventional study evaluating irinotecan (Onkovis) for treating cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer [Phase 2]
Phase 2 clinical trial update for cixutumumab (IMC-A12) in islet cell cancer, with completed status and posted results.
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
This update notes that a study evaluating the corrected QT interval with bevacizumab has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial [Phase 4]
Phase 4 trial update for a keratinocyte carcinoma chemoprevention study (VA CSP #562) has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: EBUS-TBNA Versus EBUS-TBNB [NA]
A clinical trial comparing EBUS-TBNA to EBUS-TBNB has been withdrawn from the registry, per the sponsor Royal Brompton & Harefield NHS Found…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
This completed non-interventional study evaluated the use of Docetaxel (Doce Onkovis) for the treatment of carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 pharmacology study update of Brentuximab vedotin (SGN-35) has completed, according to clinical trials data. The study involves patie…
-
EMA withdrawal · 2014-11-14EMA Withdrawn: Topotecan Eagle (topotecan hydrochloride) — Eagle Laboratories Ltd.
EMA has withdrawn Topotecan Eagle (topotecan hydrochloride) from the market.
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors [Phase 1]
Phase I pharmacokinetic/pharmacodynamic study evaluating the combination of PTK787 (Vatalanib) with Paclitaxel in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors [Phase 1]
A Phase 1 evaluation of 64Cu-DOTA-U3-1287 in subjects with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma [Phase 1]
Phase I, open-label, ascending-dose trial of SPI-1620 (Endothelin B agonist) assessing safety, tolerability, pharmacokinetics and pharmacody…
-
CLINICAL_TRIALS research · 2013-10-10Clinical Trial Update: Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma [Phase 1, Phase 2]
This document outlines an early-phase clinical trial evaluating sodium selenite as a cytotoxic agent in advanced carcinoma (Phase 1/Phase 2)…
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients [Phase 1]
This Phase 1 trial investigates the anatomical relationship between Level IB lymph nodes and the submandibular gland in cancer patients. Res…
-
CLINICAL_TRIALS research · 2013-07-15Clinical Trial Update: Definitive Therapy for Oligometastatic Solid Malignancies [Phase 2]
Phase 2 clinical trial update for definitive therapy in oligometastatic solid malignancies, including Stage IV or recurrent carcinoma or sar…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers [Phase 3]
This report notes the completion of a Phase 3b safety study evaluating catumaxomab, administered intraperitoneally, for malignant ascites ca…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma [Phase 1]
Phase 1 trial evaluating LTX-315 in combination with GV1001 as an immunologic adjunct after curative surgery for carcinoma; the study status…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Automated Telephone Monitoring for Symptom Management [Phase 2]
A Phase 2 study evaluating automated telephone monitoring for symptom management in carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Pain and Fatigue Study [NA]
A completed clinical trial from Michigan State University studying pain and fatigue in patients with carcinoma.